CLINICAL PROBLEM: Absorbent dressings typically require removal to make wound observations. Frequent dressing changes can disrupt the wound, damage surrounding tissues, cause unnecessary discomfort to the patient, decrease clinician productivity, and add to the overall cost of treatment. Two case studies are presented demonstrating utility of a new transparent absorbent acrylic dressing (TAAD) in the management of Stage II and III pressure ulcers (PU). CASE STUDY #1: A 40-year old male presented with a one month history of a Stage II pressure ulcer on his heel. Other significant medical problems included paraplegia, non-insulin dependent diabetes mellitus, hypertension, neuropathy and anemia. The patient was incontinent of urine and stool and had a Braden pressure ulcer risk assessment score of 19. Previous ulcer treatment included pressure relief and a hydrocolloid dressing. Initial ulcer size was 8.08 cm² with moderate amounts of serous drainage. CASE STUDY #2: A 75-year old male presented with a three month history of a Stage III pressure ulcer on the lateral malleolus. Other significant medical problems included CVA, dysphagia, hypothyroidism, rheumatoid arthritis, and dementia. The patient was incontinent of urine and stool and had a Braden pressure ulcer risk assessment score of 12. Initial ulcer size was 0.6 cm² with a small amount of serous drainage. Previous ulcer treatment included pressure relief and a foam dressing. CLINICAL APPROACH: For both patients pressure relief was continued and the ulcer dressing was changed to the TAAD. PATIENT OUTCOMES: Wound closure occurred in four weeks for the first patient and in eight weeks for the second patient. The dressing was highly conformable and adhered well. Transparency of the dressing allowed for inspection of the wound without removal. CONCLUSIONS: The new TAAD performed well on these Stage II and III PU.

*3M™ Tegaderm™ Absorbent Clear Acrylic Dressing